---
schema_version: "secwatch.filing_event.v1"
accession: "0001588978-23-000008"
form_type: "8-K"
ticker: "PRCT"
cik: "0001588978"
company_name: "PROCEPT BioRobotics Corp"
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T22:09:53.025589+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PROCEPT BioRobotics Q4 revenue up 135% YoY to $23.8M; guides 2023 revenue ~$125M

## Summary
- Q4 2022 revenue $23.8M (+135% YoY); full year revenue $75.0M (+118% YoY).
- U.S. handpiece/consumables revenue $10.4M (+202% YoY); system install base 167.
- Net loss Q4 $28.2M vs $18.3M prior year; full year net loss $87.2M.
- 2023 guidance: revenue ~$125M (67% growth), gross margin ~53%, operating expense ~$163M.
- Inventory write-offs of $0.7M in Q4 due to manufacturing yield issue, resolved in Q1 2023.

## SEC filing metadata
- accession: 0001588978-23-000008
- form_type: 8-K
- ticker: PRCT
- cik: 0001588978
- company_name: PROCEPT BioRobotics Corp
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1588978/000158897823000008/0001588978-23-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1588978/000158897823000008/prct-20230228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001588978-23-000008
- JSON: https://secwatch.observer/filing/0001588978-23-000008.json
- Plain text: https://secwatch.observer/filing/0001588978-23-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.